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Resolution of the covalently closed terminus of adeno-associated Virus (AAV) DNA is mediated by viral replication protein
Rep78 or Rep68. In vitro studies with purified Rep proteins indicate that concurrent with this resolution is a covalent
attachment of one of the proteins to the 5* end of the viral genome. The in vivo existence and fate of the covalently
associated Rep protein during the virus life cycle has not yet been elucidated. In this report, we use immunoprecipitation
analyses to demonstrate that the Rep78 protein is covalently attached to viral DNA in a preformed virion. The attached
Rep78 is susceptible to antibody binding and protease digestion, and the DNA linkage is susceptible to nuclease digestion,
therefore Rep78 is probably located on the outside of the particle. Rep proteins are also attached to double-stranded
replicative-form monomer (RFM) DNA in extracts from AAV and adenovirus coinfected cells. Rep protein attachment to RFM
and encapsidated AAV DNA suggest that the covalent complex is an intermediate in virus assembly. These observations
are similar to those noted by others for the autonomous parvoviruses and provide additional insights into parvovirus
assembly. q 1995 Academic Press, Inc.
INTRODUCTION allows for terminal resolution of the covalently closed
end of AAV DNA (Im and Muzyczka, 1990; Snyder et al.,
Adeno-associated virus (AAV) is a human parvovirus 1990a; Wanderling et al., 1995). During the in vitro termi-
that contains a linear, single-stranded DNA genome of nal resolution process, either Rep78 or Rep68 covalently
4680 nucleotides (Srivastava et al., 1983). Both positive attaches to the 5* terminus of AAV DNA via a tyrosine
and negative strands are packaged into a preformed linkage (Snyder et al., 1990b). After cleavage, the free 3*
empty capsid envelop, 18 –24 nm in diameter (Mayor et OH on the nicked strand serves as a primer for comple-
al., 1969; Berns and Adler, 1972). AAV requires a helper tion of second-strand DNA synthesis. Demonstration of
virus, usually adenovirus (Ad), for efficient replication (re- these in vitro enzymatic activities predicts that similar
viewed in Berns, 1990). Two AAV genetic elements are functions are performed in vivo in the AAV and Ad-coin-
essential for AAV DNA replication: 145 nucleotide termi- fected cell.
nal repeat sequences that serve as origins of DNA repli- In this report we demonstrate that the Rep78 protein is
cation and cis-acting elements for packaging of AAV DNA covalently linked to AAV DNA in infected cells. Moreover,
(McLaughlin et al., 1988; Samulski et al., 1989) and the Rep78 associates with single-stranded AAV DNA that is
replication (rep) gene which encodes at least four pro- assembled into a preformed AAV virion. Accessibility to
teins, Rep78, Rep68, Rep52, and Rep40. The Rep proteins antibodies, nucleases, and proteases indicates that
are translated from differentially spliced mRNAs that orig- Rep78 is found on the outside of the particle. The mainte-
inate from transcription promoters at map units 5 (p5) nance of the linkage throughout virion assembly sug-
and 19 (p19) (Hermonat et al., 1984; Tratschin et al., 1984; gests that the linked Rep protein may play a role in the
Mendelson et al., 1986; Trempe et al., 1987). The Rep assembly process. These observations demonstrate that
proteins are pleiotropic effectors of various functions in AAV assembly is strikingly similar to minute virus of mice
the virus life cycle. Rep78 and Rep68 are essential for (MVM) parvovirus in which the largest of the nonstruc-
AAV DNA replication (reviewed in Muzyczka, 1992), tural proteins, NS-1, also covalently associates with sin-
whereas Rep52 and Rep40 are necessary for accumula- gle-stranded viral DNA in a preformed particle (Cotmore
tion of single-stranded AAV DNA (Chejanovsky and Car- and Tattersall, 1988, 1989). These experiments provide
ter, 1989). In vitro experiments using purified Rep78 and new insight into the assembly of this important parvovi-
Rep68 have revealed that these proteins possess DNA rus.
and RNA helicase activity, ATPase activity, and a site-
MATERIALS AND METHODSspecific, strand-specific endonuclease activity that
Cells and viruses
Human 293 cells were grown in Eagle minimal essen-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (419) 382-7395. E-mail: TREMPE@GEMINI.MCO.EDU. tial medium (MEM) supplemented with antibiotics and
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10% fetal bovine serum and maintained as monolayer son et al., 1986), and a cystine was added as the 19th
amino acid to facilitate conjugation of the peptide to acultures at 377 in a 5% CO2 atmosphere. Adenovirus type
2 and adeno-associated virus type 2 were used at a m.o.i. maleimide-activated keyhole limpet hemocyanin (Pierce
Chemical Co.). Antibodies were affinity purified using theof 5 and 50, respectively. Infections were carried out
on cultures that were approximately 70% confluent. The truncated Rep protein expressed in E. coli. AAV capsid
antiserum was prepared in rabbits against CsCl2-purifiedcultures were inoculated for 1 hr in serum-free MEM.
AAV2 virus and was used for Cap protein analysis by
Cell radiolabeling and nuclear extractions Western immunoblot or immunoprecipitation.
Immunoprecipitations were carried out by first pread-
Cells were labeled with inorganic 32Pi (orthophos- sorbing Rep or Cap antibodies to protein A agarose
phate) at 0.5 mCi per milliliter in phosphate-free MEM
beads (Pierce) for 1–2 hr at 47. Nuclear extract, 1.0 ml
supplemented with 10% dialyzed fetal bovine serum, be-
(equivalent to 105 nuclei), was pretreated with 30 ml im-
tween 15 and 20 hr after virus inoculation. Labeling with
munoprecipitation (Gibco BRL) at 47 for 2–12 hr. Anti-
[35S]methionine was carried out at 80–160 mCi per millili-
body-adsorbed protein A agarose beads and nuclear ex-
ter in methionine-free MEM supplemented with 10% dia-
tracts were mixed for 2–16 hr at 47. Beads were washed
lyzed fetal bovine serum between 15 and 20 hr after virus
three times with the indicated lysis buffers and once with
inoculation. Infected cultures were harvested by scraping
25 mM Tris–HCl, pH 8.0, or with the desired buffers for
the cells into phosphate-buffered saline (PBS) containing
subsequent enzyme digestion. Immunoprecipitates were
5 mM MgCl2 (PBS/Mg). The cells were pelleted by low- extracted in sodium dodecyl sulfate–polyacrylamide gel
speed centrifugation and the cell pellet was rinsed in
electrophoresis (SDS–PAGE) sample buffer by heating
PBS/Mg and pelleted again. Nuclear extracts were pre-
for 3–5 min at 1007 before electrophoresis. Alternatively,
pared by lysing cells in 0.3 ml of ice-cold STM-NP buffer
immunoprecipitates were extracted in SE buffer (25 mM
(10 mM Tris–HCl (pH 8.0), 0.25 mM sucrose, 10 mM
Tris–Cl, pH 8.0, containing 30% glycerol, 1% SDS, and
MgCl2 , 1.0 mM phenylmethyl sulfonyl fluoride (PMSF), 100 mM b-ME) by heating at 377 for 10 min, 607 for 20
0.1 mM dithiothreitol (DTT), and 0.5% Nonidet P-40, (NP-
min, and 707 for 10 min and used immediately for SDS–
40)) for 10 min. Nuclei were pelleted by centrifugation at
agarose gel analysis.
1000 g for 10 min at 47. The pelleted nuclei were stored
Immunoprecipitates extracted in SDS–PAGE sample
at0707 in lysis buffer or were used immediately. Pelleted
buffer were electrophoresed on 10% SDS–polyacryl-
nuclei were suspended in 0.3 ml of IPP buffer (50 mM
amide gels and electrophoretically transferred to nitro-
Tris–Cl, pH 8.0, 150 mM NaCl, 20 mM EDTA, 0.5% NP-
cellulose sheets using a dry-blot apparatus (USA Scien-
40, 1.0 mM PMSF, 0.1 mM DTT, 0.1 mg per milliliter
tific Plastic). Membranes were soaked in blocking buffer
leupeptin, 0.1 mg per milliliter pepstatin, and 0.1 mM
(PBS containing 5% dry milk) for 1–2 hr and then incu-
benzamidin), RIPA buffer (50 mM Tris–Cl, pH 8.0, con-
bated with affinity-purified rabbit anti-Rep antibodies or
taining 150 mM NaCl, 0.5% DOC, 0.1% SDS, 1% NP-40,
rabbit anti-Cap antisera that were diluted 1:200 in PBS
and protease inhibitors), TE buffer (50 mM Tris–Cl, pH
containing 1% dry milk for 1–2 hr at room temperature
8.0, containing 5 mM EDTA and protease inhibitors), or
or overnight at 47. After three 5-min washes with PBS
ISB buffer (IPP buffer containing 1% SDS and 50 mM b-
containing 0.05% Tween-20, the membranes were incu-
mercaptoethanol). When IPP buffer or RIPA buffer were
bated for 1 hr at room temperature with goat anti-rabbit
used, the nuclear suspensions were incubated in an ice
immunoglobulin G coupled to alkaline phosphatase
bath for 30 min; when TE buffer was used, nuclear sus-
(Pierce) diluted 1:3000 with PBS containing 1% dry milk.
pensions were frozen and thawed three times followed
After three washes with PBS–Tween buffer, color was
by centrifugation at 10,000 g for 10 min. For preparation
developed using NBT and BCIP as suggested by the
of extracts under denaturing conditions, nuclei were pel-
manufacturer. If necessary, the membranes were then
leted by low-speed centrifugation, resuspended in ISB
exposed to Kodak (Rochester, NY) X-Omat XAR-5 X-ray
buffer, heated at 807 for 30 min, and diluted 10-fold with
film.
IPP buffer before use in immunoprecipitation experi-
ments. SDS–agarose gel electrophoresis
Antibodies, immunoprecipitations, and Western Immunoprecipitates in SE buffer were electrophoreti-
blotting cally resolved on 1% agarose gels made in 11 Tris–
Acetate–EDTA with 0.2% SDS. After electrophoresis, the
Rep protein-specific antibodies were obtained from
gels were fixed in 40% methanol and 10% acetic acid
rabbits immunized with a truncated Rep protein ex-
and dried.
pressed in Escherichia coli (Trempe et al., 1987). Oligo-
peptide antisera were raised in rabbits against a 19- Sucrose gradients
amino-acid synthetic peptide, S18K. The first 18 amino
acids of S18K were deduced from the nucleotide se- Nuclear extracts (0.2 ml) in IPP buffer or TE buffer were
layered onto 4-ml, 15–30% sucrose gradients which werequence of AAV2 from nucleotides 1866 to 1919 (Mendel-
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prepared in the same buffers. The extracts were centri- and VP1 (MW, 87,000) led us to investigate whether these
were the same proteins.fuged in an SW61 rotor (Beckman Instruments) for 2 hr
at 35,000 rpm and 157. Sixteen fractions of 0.25 ml were In order to determine if Rep proteins are associated
with VP1 in the nucleus of Ad- and AAV-infected cells,collected from the top of the gradient and analyzed by
immunoprecipitation followed by Western immunoblot or Rep proteins were immunoprecipitated, separated by
SDS–PAGE, and then analyzed by Western blot usingSDS–agarose gel analysis.
either Rep (Figs. 2A and 2C)- or Cap-specific (Figs. 2B
and 2D) antisera. Immunoprecipitations with Rep anti-Enzyme digestion
bodies raised against the E. coli-expressed Rep protein
After immunoprecipitation, agarose beads were followed by Western blot analysis with Rep antibodies
washed once in the buffer that was used for immunopre- allowed for the visualization of the four Rep proteins (Fig.
cipitation, resuspended in 20 ml of appropriate buffer 2A, lane I, Rep Abs). When similar Rep-specific immuno-
(as directed by the manufacturers), and digested for the precipitates were subjected to Western immunoblot anal-
indicated lengths of time at 377 as follows: micrococcal ysis with Cap antibodies, the three Cap proteins were
nuclease (Sigma Chemical Co.), 0.1 mg per milliliter, in detected (Fig. 2B, lane I, Rep Abs). Under moderately
the presence of 5 mM CaCl2 , the reaction was stopped denaturing conditions, Rep antibodies immunoprecipi-
by addition of 20 mM EGTA (ethylene glycol-bis(b-amino- tated all four Rep proteins (Fig. 2A, lane I*, Rep Abs);
ethyl ether N,N,N*,N*-tetraacetic acid); bovine pancreatic however, coprecipitation of Cap proteins decreased
DNaseI (Sigma), 0.1 mg per milliliter, the reaction was somewhat (Fig. 2B, lane I*, Rep Abs). For an additional
stopped by the addition of EDTA; proteinase K (Boeh- verification that Rep antisera immunoprecipitate Cap pro-
ringer), 0.1 mg per milliliter, in the presence of 0.5% SDS, teins, Rep-specific peptide antibodies were used. When
the reaction was stopped by addition of protease inhibi- these immunoprecipitates were analyzed by immunoblot
tors 1.0 mM PMSF, 0.1 mM DTT, 0.1 mg per milliliter with anti-Cap sera, Cap proteins were detected (Fig. 2D,
leupeptin, 0.1 mg per milliliter pepstatin, and 0.1 mM lane I, S18K Abs). Neither type of Rep antibodies immu-
benzamidine. When immunoprecipitation followed en- noprecipitated Rep or Cap proteins from a nuclear extract
zyme digestion, the reactions were stopped as described of uninfected cells (Figs. 2A–D, lane U, Rep Abs, and
above. Samples were to be analyzed by SDS–agarose lane U, S18K Abs). These results suggest that at least one
gel electrophoresis, and 20 ml of 21 SE buffer was added of the Rep proteins is associated with the Cap proteins or
to the samples followed by heating to 707 and immediate the Rep antibodies directly react with capsid proteins.
electrophoresis. Samples to be analyzed by SDS–PAGE The latter possibility is unlikely because neither Rep anti-
were suspended in 20 ml of 21 sample buffer and heated sera precipitated purified virus particles (Figs. 2B, lane
to 707 prior to electrophoresis. AAV, Rep Abs, and 2D, lane AAV, S18K Abs), indicating
that the Rep antibodies do not cross-react with Cap pro-
RESULTS teins under the immunoprecipitation conditions used in
these experiments. Also, the Rep antibodies did notRep protein-specific antibodies coprecipitate capsid
cross-react with Cap proteins in Western immunoblotsproteins
(Figs. 2A, lane AAV, and 2C, lane AAV). Preimmune serum
did not precipitate Rep or Cap proteins from the nuclearIn order to determine if any viral or cellular proteins
associate with AAV Rep proteins, immunoprecipitation extracts obtained from uninfected (Figs. 2A–D, lane U,
Pre) or Ad- and AAV-infected (Figs. 2A–D, lane I, Pre)experiments were performed using anti-Rep specific an-
tisera. Human 293 cells were infected with AAV, Ad, or cells.
In order to provide more direct evidence that the 90-AAV plus Ad and isotopically labeled with [35S]Met. In-
fected cells were lysed and nuclear extracts prepared. kDa protein was VP1, AAV and Ad-coinfected cells were
labeled with [35S]Met. Immunoprecipitates from nuclearRep protein-specific antibodies immunoprecipitated all
four Rep proteins from AAV- and Ad-infected cells (Fig. extracts were prepared using Rep or Cap antibodies and
resolved by SDS–PAGE. After transfer to a nitrocellulose1A, lane AAV / Ad). An additional protein of 90 kDa
(p90) was consistently coprecipitated from AAV and Ad membrane, the proteins were reacted with Rep antibod-
ies (Fig. 3B, lane 4) or with Cap antibodies (Fig. 3B, lanesextracts. The coprecipitated p90 was found only in the
nucleus (Fig. 1B, lane I, Nu) of Ad- and AAV-infected 5 and 6). The autoradiograph of the membrane (Fig. 3A,
lanes 1 and 2) shows the position of the coprecipitatedcells. Rep 78 and Rep 68 were present primarily in the
nucleus (lane I, Nu), whereas Rep52 and Rep40 were 90-kDa protein. p90 on the autoradiograph and VP1 on
the immunoblot membrane perfectly align with one an-equally distributed between nucleus and cytoplasm (lane
I, Nu and I, Cyt). Immunoprecipitations performed under other, suggesting that p90 is the Cap protein VP1. When
Rep antiserum was used for immunoblot analysis aftermoderately denaturing conditions prevented some, but
not all of, p90 precipitation (unpublished observation and immunoprecipitation, Rep 78 is more abundant than
Rep68 (Fig. 3B, lane 4). However, the autoradiogram ofFig. 2). The identity of p90 was not immediately obvious
but the similarities in molecular weights between p90 this sample indicates that Rep78 and Rep68 are nearly
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FIG. 1. Coprecipitation of a 90-kDa protein with Rep protein-specific antibodies. (A) Nuclear extracts from uninfected (—), adenovirus-infected
(Ad), adeno-associated virus-infected (AAV), or adenovirus plus adeno-associated virus-infected (Ad/ AAV) cells, metabolically labeled with [35S]Met,
were immunoprecipitated with Rep antibodies and analyzed by SDS–PAGE and autoradiography. Lane M contains 14C-labeled protein molecular
weight markers. (B) Nuclear (Nu), cytoplasmic (Cyt), or total (Total) cell extracts from uninfected (U) or adenovirus plus adeno-associated virus-
infected (I) cells metabolically labeled with [35S]Met and analyzed as in (A). The numbers to the left of the figure indicate the size and location of
the 14C-labeled (A) or prestained (B) molecular weight markers. The coprecipitated 90-kDa protein and AAV Rep proteins are indicated to the right.
equal in abundance (Fig. 3A, lane 1). We believe that cipitate Rep proteins (lanes IPP, Cap and ISB, Cap). Cap
antibodies precipitated lesser amounts of Cap proteinsmost of the radiolabel comes from VP3, which comigrates
with Rep68. These results and those in Fig. 2 suggest under denaturing conditions. We believe that the lower
efficiency of immunoprecipitates found in denaturedthat the Rep proteins are associated with a preformed
virion particle and this association allows for Rep anti- samples is because the Cap antiserum was prepared
against native AAV particles. Thus, when the virion isbodies to coimmunoprecipitate an AAV virion.
denatured, monomeric Cap proteins are not as easily
recognized by antibodies and are immunoprecipitatedDenaturation disrupts the Rep–Cap complex
with a lower efficiency.
Nuclear extracts were prepared from AAV- and Ad-
infected 293 cells, and AAV proteins were immunoprecip- Rep protein is tightly associated with single-stranded
itated with anti-Rep or anti-Cap serum under conditions and RFM AAV DNA
that disrupt virions. The proteins were separated by
SDS–PAGE and then analyzed by Western blot with anti- Mixing experiments were performed to determine if
Rep proteins spontaneously associate with AAV parti-Rep (Fig. 4A) or anti-Cap (Fig. 4B) serum. Rep antibodies
immunoprecipitated similar amounts of Rep proteins cles. When purified AAV was mixed with cellular extracts
containing Rep78 protein, Rep–AAV complexes were notwhen the samples were prepared in nondenaturing (IPP)
or denaturing (ISB) buffers (Fig. 4A, lane, IPP, Rep and detected in coimmunoprecipitations (unpublished obser-
vation). Therefore, we looked for Rep association withISB, Rep). Rep antibodies coprecipitated Cap proteins
when the extracts were prepared in IPP buffer (Fig. 4B, virions that were mediated by a linkage to AAV DNA. To
provide in vivo evidence for the existence of a covalentlane Rep, IPP), but failed to coprecipitate Cap proteins
when the sample was prepared in ISB buffer and heated attachment between Rep protein and AAV DNA, Ad- and
AAV-infected 293 cells were metabolically labelled withat 807 (Fig. 4B, lane Rep, ISB). When the supernatant
from the Cap precipitation was reimmunoprecipitated inorganic phosphate (32Pi) between 15 and 20 hr after
infection. Cells were harvested at the end of labelingwith Rep antiserum, the Rep proteins were still present
and able to react with the appropriate antibodies (lane (Fig. 5A, lanes 1–6) or following 6 hr chase with cold Pi
(Fig. 5A, lanes 7–9). Nuclear extracts were prepared un-Rep*). Thus, denaturation prevented Rep-mediated im-
munoprecipitation of viral structural proteins. These re- der native conditions and immunoprecipitated with Rep
(Fig. 5A, lanes 4–9) or Cap (Fig. 5A, lanes 1–3) antibod-sults indicate that the Rep–Cap complex is sensitive to
denaturation. Cap antibodies precipitated Cap proteins ies. Immunoprecipitates were left untreated (lanes 1, 4, 7)
or treated with proteinase K (lanes 2, 5, 8) or micrococcalunder both native and denaturing conditions (Fig. 4B,
lanes IPP, Cap and ISB, Cap), whereas they did not pre- nuclease (lanes 3, 6, 9) and analyzed by SDS–agarose
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FIG. 2. Detection of Cap proteins in immunoprecipitations using Rep-specific antibodies. Nuclear extracts from uninfected cells (U), Ad / AAV-
infected cells (I), or CsCl2-purified AAV (AAV) were immunoprecipitated with preimmune serum (Pre), Rep antibodies (Rep Abs), or Rep peptide
antibodies (S18K Abs). Precipitates were analyzed by SDS–PAGE followed by immunoblotting with Rep (A and C) or Cap (B and D) antibodies.
Lane 1* contains nuclear extracts, prepared and immunoprecipitated in RIPA buffer, with Rep antibodies (A and B) and S18K Abs (C and D). The
last lane in each panel (AAV) contains CsCl2-purified AAV particles directly loaded onto the gel. The numbers to the left of the figure indicate the
size and location of the prestained molecular weight markers. AAV Cap and Rep proteins are indicated to the right of the figure.
gel electrophoresis and autoradiography. Rep antibodies tions. Nuclear extracts were treated with 1% SDS and 50
mM b-ME and heated to 807 for 30 min. The extractsprecipitated both single-stranded (ss) and RFM AAV DNA.
However, proteinase K treatment of Cap immunoprecipi- were then cooled, diluted 10-fold, and immunoprecipi-
tated with Rep- or Cap-specific antibodies. The samplestates did not affect the mobility of RFM and ssDNA (Fig.
5A, lane 2). The increase in mobility of the DNA from Rep were then analyzed by SDS–agarose gel electrophoresis
and autoradiography. Cap antibodies did not precipitateimmunoprecipitations is probably due to the removal of
Rep protein. Most of the Cap immunoprecipitate does any AAV DNA under these conditions (Fig. 5B, lane 1).
However, when the supernatant from the Cap-immuno-not have the covalently bound Rep protein; therefore,
there is no change in mobility. Micrococcal nuclease precipitated sample was reimmunoprecipitated with Rep
antibodies, AAV DNA was detected (Fig. 5B, lane 5). Reptreatment of the Rep immunoprecipitates (Fig. 5A, lanes
6 and 9) before SDS–agarose gel analysis digested all antibodies precipitated RFM AAV DNA, indicating that the
Rep–DNA complex is resistant to protein denaturation.RFM DNA. However, a portion of ssDNA was not accessi-
ble to nuclease, suggesting that this Rep-associated If proteinase K treatment preceded gel electrophoresis
of the Rep-immunoprecipitated material, then the RFMssDNA is attached to the Rep protein and packaged into
a virion, which protects the ssDNA from nuclease diges- migrated further (Fig. 5B, lane 3). The faster mobility is
presumably due to removal of a covalently attached Reption. Micrococcal nuclease treatment also generated a
faster migrating ssDNA species, indicating that the DNA protein. Micrococcal nuclease treatment of Rep-specific
immunoprecipitates resulted in complete loss of AAVlinkage between Rep and Cap proteins is accessible to
nuclease. DNA (lane 4). In these experiments, the denaturation step
was followed by a 1-hr incubation at 377 in the presenceAttachment of a Rep protein to AAV DNA was more
evident when immunoprecipitations were carried out of proteinase K or micrococcal nuclease. During the incu-
bation period, single-stranded AAV DNA will reannealwith nuclear extracts prepared under denaturing condi-
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present predominantly in first three fractions (unpub-
lished observation).
Cap-specific Western immunoblot analysis of the frac-
tions across the gradient showed that the Cap proteins
were present in fractions 7–13 (Fig. 6A). (The band in
fractions 1–5 is an artifact that is also detected in West-
ern blots using preimmune serum.) Cap proteins are syn-
thesized and assembled into a virion structure into which
a single-strand viral genome will be packaged. Since Cap
proteins are not observed in the gradient at a position
corresponding to a monomeric form, fractions 7–13 ap-
pear to contain preformed virions. Immunoprecipitation
of gradient fractions with Rep antisera followed by West-
ern blot with Cap antisera revealed that Rep proteins are
present with virion particles (Fig. 6B, fractions 8–11). In
a parallel gradient containing CsCl2-purified AAV, mature
virions sediment relatively faster (Fig. 6C). Thus, Rep pro-
tein-associated virus particles sediment relatively slower
FIG. 3. p90 is VP1. Nuclear extracts from Ad / AAV-infected cells,
metabolically labeled with [35S]Met, were immunoprecipitated with Rep
or Cap antibodies. Precipitates were resolved on SDS–PAGE, trans-
ferred to nitrocellulose membrane, and analyzed by (A) autoradiography
or (B) immunoblotting with Rep (lane 4) or Cap (lanes 5 and 6) antibod-
ies. The labeling at the top of the figure refers to the type of antibody
used for immunoprecipitation and the labeling at the bottom of the
figure refers to the antibodies used for Western analyses. p90 and the
AAV Rep proteins are indicated to the left and AAV Cap proteins are
indicated to the right of the figure.
such that the majority of the DNA seen in these experi-
ments is RFM and little ssDNA is observed.
For a further verification that a Rep protein is covalently
associated with AAV DNA, 32P-labeled nuclear extracts
in TE buffer from AAV- and Ad-infected cells were treated
with proteinase K or micrococcal nuclease before immu-
noprecipitation. Proteinase K prevents Cap antibodies
from bringing down AAV DNA (Fig. 5C, lane 2). Nuclease
treatment did not affect Cap immunoprecipitation (lane
3). However, both protease (lane 5) and nuclease (lane
6) treatments prevented Rep antibodies from immuno-
precipitating AAV DNA. These experiments strongly sug-
gest that one of the AAV Rep proteins is covalently asso-
ciated with both RFM and ss AAV DNA.
Single-strand AAV DNA attached to the Rep protein is
packaged into a virion
In order to determine if the Rep–ssDNA complex ex-
FIG. 4. Western blot analysis of immunoprecipitations under nativeists in a viral particle, we fractionated native nuclear
and denaturing conditions. Nuclear extracts from Ad / AAV-infectedextracts from Ad and AAV-coinfected cells, on 15 to 30%
cells were prepared in IPP or ISB buffer (see Materials and Methods
sucrose gradients. Western immunoblot analysis of su- for details) and immunoprecipitated with Rep (Rep) or Cap (Cap) anti-
crose gradient fractions with Rep antibodies showed that bodies. Precipitates were analyzed by immunoblotting with Rep (A) or
Cap (B) antibodies. Supernatant from Cap immunoprecipitations in ISBRep78 was predominantly present in fractions 1–6 (un-
was reprecipitated with Rep antibodies (Rep*). Lane S contains thepublished observation). However, when the fractionation
unfractionated extract from Ad / AAV-infected cells. The positions andwas carried out in RIPA buffer, which disrupts most non-
sizes of prestained molecular size markers that were coelectro-
covalent interactions but does not disrupt the viral cap- phoresed with immunoprecipitates are indicated to the left of (A) and
sid, Rep78 was predominantly present in fractions 1– 3. (B). AAV Rep and Cap proteins are indicated to the right of (A) and (B),
respectively.Under both conditions Rep68, Rep52, and Rep40 were
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FIG. 5. AAV DNA is associated with immunoprecipitated Rep proteins. Ad- and AAV-infected cells were labeled with 32Pi between 15 and 20 hr
after infection. (A) Cells were harvested at the end of labeling (20 hr postinfection; lanes 1–6) or after chase with cold inorganic phosphate (lanes
7– 9) for 6 hr. Nuclear extracts were prepared and immunoprecipitated with Cap or Rep antibodies (as indicated above each panel). Precipitates
were washed and resuspended in 20 ml of the appropriate buffers (see Materials and Methods) and treated with proteinase K (lanes 2, 5, 8) or
micrococcal nuclease (lanes 3, 6, 9) or were left untreated (lanes 1, 4, 7). After digestion, the samples were separated on an SDS–agarose gel
and the DNA was visualized by autoradiography. (B) Cells were harvested at the end of labeling and nuclear extracts were prepared in ISB buffer,
heated at 807 for 30 min, diluted 10-fold with IPP buffer, and immunoprecipitated with Cap (Cap) or Rep (Rep) antibodies. Precipitates were treated
with proteinase K (lane 3) or micrococcal nuclease (lane 4) and analyzed as described in (A). Lane 5 (Rep*) contains supernatant from Cap
immunoprecipitations reprecipitated with Rep antibodies. (C) Cells were harvested at the end of labeling and nuclei extracts were prepared and
treated with micrococcal nuclease (lanes 3 and 6), or proteinase K (lanes 2 and 5), for 1 hr at 377. Samples were diluted 10-fold and immunoprecipitated
with Cap (Cap) or Rep (Rep) antibodies. Precipitates were analyzed as described in (A). DNA size markers are indicated to the left of each panel.
Positions of RFM and ss AAV DNA are indicated to the right.
than Rep protein-free virus particles during sucrose gra- extensive treatment of the covalent AAV DNA–Rep pro-
tein complex with nucleases, the terminal phosphatedient sedimentation.
To detect AAV DNA, nuclear extracts were prepared from the 5* end of the DNA is transferred to the protein.
We used this characteristic to determine which of thefrom AAV and Ad-coinfected cells that had been in vivo
labeled with inorganic 32P and separated on sucrose Rep proteins is linked to AAV virions. Sucrose gradient
fractions 1–2 and 8–13, from gradients prepared withgradients. Immunoprecipitation with Cap antibodies fol-
lowed by SDS–agarose gel electrophoresis allowed for 32P-labeled AAV- and Ad-infected nuclear extracts, were
pooled and denatured under conditions that will disruptthe detection of ssDNA and RFM DNA from fractions 9–
AAV virions. The pooled fractions were immunoprecipi-16 (Fig. 7A). Immunoprecipitation with Rep antibodies
tated with Rep antisera and half of the precipitated mate-from 32P-labeled cultures allowed for the detection of RFM
rial was extensively treated with DNaseI and micrococcalDNA from fractions 3–6 and ssDNA from fractions 9–13
nuclease. The nuclease-treated and untreated samples(Fig. 7B). Both Rep and Cap antibodies brought down
were analyzed by SDS–PAGE and autoradiography.subgenomic-length DNA. In lanes 3–6, the subgenomic-
Upon nuclease treatment of pooled fractions 8–13, alength DNA probably represents replicative intermedi-
protein of the same molecular weight as Rep78 enteredates whereas in lanes 9–16 this DNA species may repre-
the gel, whereas this species was not detected in thesent partially packaged ssDNA or defective interfering
absence of nuclease digestion (Fig. 8). Given that thegenomes. Comparison of Figs. 7A and 7B reveals that
precipitations were performed under denaturing condi-the peak of ssDNA immunoprecipitated by Cap antisera
tions, and that the DNA that is brought down by Rep(fractions 12–13) is shifted down the gradient compared
antibodies is AAV DNA, we believe that the 78-kDa pro-to the peak of ssDNA precipitated by Rep antiserum.
tein freed by nuclease digestion is indeed Rep78. TheThus, Rep-associated particles have a slower mobility
identity of the other prominent bands in these lanes re-than Rep-deficient particles.
mains to be determined. Similar treatments of pooled
Rep78 is associated with AAV particles fractions 1 and 2 did not show any obvious differences
Both Rep68 and Rep78 can be covalently linked to between the nuclease-treated (/) and untreated (0)
samples. Similar results are observed if individual frac-AAV DNA in vitro (Snyder and Muzyzcka, 1990b). Upon
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FIG. 6. Sucrose gradient analysis of Rep–Cap complexes. Nuclear extracts from Ad- and AAV-infected cells were fractionated on sucrose gradients
and the fractions analyzed by immunoprecipitation, SDS–PAGE, and Western blot, as described under Materials and Methods. Gradient fractions
were analyzed by (A) Western blotting with Cap antibodies or (B) immunoprecipitation with Rep antibodies followed by Western blotting with Cap
antibodies. (C) A parallel gradient containing CsCl2-purified AAV particles and analyzed by immunoblotting with Cap antibodies. Lane S contains
the crude material applied to the gradient. The arrow indicates the direction of sedimentation. Numbers at the top of the figure indicate the number
of fractions from top to bottom (1–16) of the gradient. AAV Cap proteins are indicated to the right of the figure. The heavy band in the middle of
(B) is from immunoglobulin heavy chain.
tions across the gradient are analyzed by SDS–PAGE tated material, we identified the 90-kDa protein as the
largest AAV structural protein, VP-1. The Rep protein’s(unpublished observation). It should also be noted that
association with VP-1 was due to an association withthe Rep78 protein that is linked to AAV DNA cannot enter
the entire virion because VP-2 and VP-3 were also copre-the SDS protein gel unless the DNA is degraded and the
cipitated. Since AAV Cap proteins usually do not existRep proteins that were detected in Figs. 1–4 were not
as monomers, we believe that the Rep protein is associ-linked to AAV DNA. Another important observation from
ated with a virion particle. These observations are alsothis experiment is that all four Rep proteins were de-
consistent with a report that AAV Rep and Cap proteinstected in the absence of nuclease digestion in fractions
colocalize in nuclei of AAV- and Ad-infected cells (Hunter1 and 2. This suggests that all four species are phosphor-
and Samulski, 1992).ylated in AAV- and Ad-infected cells.
Both RFM and ssDNA were immunoprecipitated with
Rep antisera and these interactions were maintained un-DISCUSSION
der denaturing conditions. However, denaturation of AAV
To determine if the AAV Rep proteins interact with virions prevented Rep antisera from precipitating Cap
other viral or cellular proteins in infected cells, we per- proteins. Protease or nuclease digestion of the Rep–Cap
formed a series of immunoprecipitation experiments us- particle prevented Rep-specific immunoprecipitation of
ing Rep protein-specific antisera. A 90-kDa nuclear pro- AAV DNA or Cap proteins. Thus, the accessibility to these
tein was consistently associated with Rep proteins. The treatments, as well as accessibility to antibodies, indi-
90-kDa protein did not completely disappear when immu- cates that the Rep protein is located on the exterior of
noprecipitations were performed under moderately dena- the virion. Separation of AAV particles from RFM DNA
turing conditions. When Western blot analyses using Rep indicated that it is the Rep78 form of the protein that is
associated with the particle. The resistance to SDS, highand Cap antisera were performed on immunoprecipi-
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FIG. 7. DNA analysis of sucrose gradient fractions. AAV- and Ad-infected cells were labeled with 32Pi between 15 and 20 hr after infection.
Nuclear extracts were prepared and layered on sucrose gradients. The gradient was fractionated and immunoprecipitated with Cap (A) or Rep (B)
antibodies. Precipitates were resolved on SDS–agarose gels and the DNA was visualized by autoradiography. Numbers at the top of the figure
indicate fraction number from the top to the bottom of the gradient and arrows refer to the direction of sedimentation. Lanes marked Rep or Cap
are immunoprecipitations of the crude extracts with those antibodies. Numbers to the left of the figure indicate the DNA size markers.
temperature, and b-ME suggests that the Rep–AAV DNA new strand continues, the Rep-associated DNA would
be displaced from its complement and inserted into aassociation is due to a covalent linkage. Therefore, the
Rep–Cap association is mediated through covalent link- preformed capsid structure. The associated Rep protein
age to single-stranded AAV DNA in the virion. The main- may serve to precisely position the empty capsid for
tenance of the Rep–AAV DNA linkage from RFM to ssDNA assembly. Such a model has been proposed for the au-
suggests that the Rep78 protein plays a role in encapsi- tonomous parvovirus MVM (Cotmore and Tattersall,
dation. After making the cut at the terminal resolution 1988, 1989). The 5* ends of all newly synthesized single
site and attaching to the 5* end of the DNA, the comple- strands of MVM DNA are covalently linked to the largest
mentary strand could form a hairpin and new synthesis nonstructural protein, NS-1, which is the functional homo-
would begin at the free 3* OH. As 5* r 3* synthesis of the logue of Rep78. The covalently associated NS-1 remains
linked to the genome after it is inserted into the pre-
formed capsid. Based on the data presented here, the
MVM model may be extended to AAV, too. Following the
MVM paradigm, we expect that both plus and minus
strands of AAV DNA, which are packaged with equal
efficiency, will contain covalently attached Rep78 (or
Rep68). These investigations are currently underway in
our laboratory.
Our observation of an in vivo, covalent attachment of
the Rep78 protein to AAV DNA in infected cells is consis-
tent with studies that demonstrate this linkage in vitro
using purified Rep78 and Rep68 proteins and AAV termini
(Snyder et al., 1990a,b; Im and Muzyczka, 1990). Site-
specific and strand-specific cleavage at the viral terminal
resolution site is accompanied by attachment to the 5*
end of the genome (Snyder et al., 1990b). This process
allows for completion of the strand-transfer process that
is characteristic of the replication of parvovirus terminiFIG. 8. Rep78 is associated with virions. AAV- and Ad-infected cul-
tures were radiolabeled, and nuclear proteins isolated and fractionated (Cavalier-Smith, 1974). The site of in vitro cleavage has
on sucrose gradients as described in the text. Fractions 1–2 and 8– been found 5* to any of the underlined nucleotides in
13 were pooled and analyzed by SDS–PAGE and autoradiography.
the following terminal resolution sequence from the AAVOne-half of the pooled fractions was digested extensively with DNaseI
genome: 5*-GAGTTGG-3*. These cut sites correspond toand micrococcal nuclease before electrophoresis (/). The other half
of the pool was not treated prior to electrophoresis (0). the 5* terminal DNA sequences (5* TTG) obtained from
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AAV virion DNA in which 50% lack the first T and 15% observation). Therefore, Rep must detach from the virion
by some yet to be defined mechanism. In the case oflack both Ts (Fife et al., 1977). We are currently verifying
if the Rep proteins are attached to the 5* ends of the MVM, NS-1 can remain attached to the virion after the
mature particle is released from the cell. Moreover, thegenome and where the in vivo linkage is located. Our
results suggest that the Rep78–AAV DNA linkage is co- NS-1-associated virion is infectious, although the protein
is degraded in the cell culture medium or soon after thevalent, consistent with the MVM precedent and the in
vitro work of others. Thus, our work is an in vivo demon- virus enters the cell (Cotmore and Tattersall, 1988, 1989).
The external location of the Rep78 protein would makestration of what had previously been shown in vitro.
The sedimentation properties of the Rep-associated it susceptible to degradation upon entry into the cell.
However, if Rep78 enters the cell it will be interesting toparticle appear to be consistent with an assembly com-
plex described by Myers and Carter (1980). In this report, determine if it, or any of its degradation products, retains
any function. We are currently investigating whethera 60S particle called AAV(SP), was found to have the
same DNA to protein ratio as mature AAV. The DNA Rep78 remains attached to a fully mature, infectious vi-
rion and what role it plays in the virus life cycle. If theassociated with AAV(SP) was approximately 82% sensi-
tive to DNase treatment. AAV(SP) was proposed to be linkage is reasonably stable then the Rep-associated
AAV may be a common form of the virus that is prevalentan empty capsid associated with AAV DNA molecules in
a structure which has a more open conformation than during natural infections.
that of mature particles. The location of the Rep–AAV
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